Moneycontrol PRO
Loans
Loans

business

Expect 22-25% revenue growth for FY14: Suven Life Sciences

Suven Life Sciences aims to clock 22-25 percent revenue growth in FY14.

first published: May 17, 2013 04:18 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347